MFMPX
Price
$15.64
Change
+$0.15 (+0.97%)
Updated
Dec 20 closing price
RNWFX
Price
$77.72
Change
+$0.12 (+0.15%)
Updated
Dec 20 closing price
Ad is loading...

MFMPX vs RNWFX

Header iconMFMPX vs RNWFX Comparison
Open Charts MFMPX vs RNWFXBanner chart's image
Morgan Stanley Inst Next Gen Em Mkts A
Price$15.64
Change+$0.15 (+0.97%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$77.72
Change+$0.12 (+0.15%)
VolumeN/A
CapitalizationN/A
MFMPX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MFMPX vs. RNWFX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFMPX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 62.2B vs. MFMPX (21.2M). RNWFX pays higher dividends than MFMPX: RNWFX (1.51) vs MFMPX (0.92). MFMPX was incepted earlier than RNWFX: MFMPX (12 years) vs RNWFX (23 years). MFMPX (33.00) and RNWFX (32.00) have comparable annual turnover. RNWFX has a lower initial minimum investment than MFMPX: RNWFX (250) vs MFMPX (1000). MFMPX annual gain was more profitable for investors over the last year : 11.00 vs. RNWFX (5.86). RNWFX return over 5 years is better than : 14.39 vs. MFMPX (-4.10).
MFMPXRNWFXMFMPX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years23 years-
Gain YTD9.9424.549219%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets21.2M62.2B0%
Annual Yield % from dividends0.921.5161%
Returns for 1 year11.005.86188%
Returns for 3 years-26.23-5.10514%
Returns for 5 years-4.1014.39-29%
Returns for 10 years-12.2942.67-29%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS12.520.39
+3.22%
Viatris
TEO11.890.14
+1.19%
Telecom Argentina SA
DX12.570.14
+1.13%
Dynex Capital
INTT7.680.04
+0.52%
inTEST Corp
VIRX0.21N/A
-1.87%
Viracta Therapeutics